SEATTLE, Nov. 19, 2015 /PRNewswire/ -- Stratos Group today announced the addition of Chris Rivera to its Board as a Life Science Advisor.
Chris brings extensive experience in the life sciences to Stratos, including seven years as the President and CEO of the Washington Biotechnology & Biomedical Association, where he fostered remarkable growth of the sector in Washington State. Prior to the WBBA, he spent more than 25 years at biotechnology companies, including Hyperion Therapeutics, where he was Founder and CEO, and Genzyme and Tercica, where he was Senior Vice President.
Chris's passion for groundbreaking science and technology that will improve people's lives will be very complementary to Stratos Group's goals. "We are confident that the addition of Chris to the team will yield considerable results," Allan Stephan, Chief Executive Officer, said. "His demonstrated ability to identify early stage investment opportunities and mentor life sciences ventures will be major assets to our organization."
"I am very excited to be joining Stratos' Board of Advisors," said Chris Rivera. "Stratos has a proven track record of innovation that has made significant contributions to the life science industry. I am looking forward to contributing to future innovations that will help impact human health."
About Stratos Group LLC
Stratos Group is dedicated to the conversion of science and technology into commercial solutions for the advancement of mankind and the protection of the environment. Also under the Stratos Group umbrella is Stratos Product Development. Stratos Product Development is a world leader in innovation and high tech product development services.
Press release distributed by PRLog
SOURCE Stratos Group